Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.

Riou O, Llacer Moscardo C, Fenoglietto P, Deshayes E, Tetreau R, Molinier J, Lenglet A, Assenat E, Ychou M, Guiu B, Aillères N, Bedos L, Azria D.

Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):103-110. doi: 10.1016/j.rpor.2017.02.006. Epub 2017 Apr 6.

PMID:
28490980
2.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.

Bossé D, Ng T, Ahmad C, Alfakeeh A, Alruzug I, Biagi J, Brierley J, Chaudhury P, Cleary S, Colwell B, Cripps C, Dawson LA, Dorreen M, Ferland E, Galiatsatos P, Girard S, Gray S, Halwani F, Kopek N, Mahmud A, Martel G, Robillard L, Samson B, Seal M, Siddiqui J, Sideris L, Snow S, Thirwell M, Vickers M, Goodwin R, Goel R, Hsu T, Tsvetkova E, Ward B, Asmis T.

Curr Oncol. 2016 Dec;23(6):e605-e614. doi: 10.3747/co.23.3394. Epub 2016 Dec 21.

3.

Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map.

Tani S, Tatli S, Hata N, Garcia-Rojas X, Olubiyi OI, Silverman SG, Tokuda J.

Int J Comput Assist Radiol Surg. 2016 Jun;11(6):1133-42. doi: 10.1007/s11548-016-1398-z. Epub 2016 Apr 2.

4.

Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view.

Lee JY, Kim YH, Roh YH, Roh KB, Kim KW, Kang SH, Baek YH, Lee SW, Han SY, Kwon HJ, Cho JH.

Ann Surg Treat Res. 2016 Mar;90(3):147-56. doi: 10.4174/astr.2016.90.3.147. Epub 2016 Feb 26.

5.

Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis.

Brandi G, De Lorenzo S, Nannini M, Curti S, Ottone M, Dall'Olio FG, Barbera MA, Pantaleo MA, Biasco G.

World J Gastroenterol. 2016 Jan 14;22(2):519-33. doi: 10.3748/wjg.v22.i2.519. Review.

6.

Therapeutic Potential of Adjuvant Stereotactic Body Radiotherapy for Gallbladder Cancer.

Mahadevan A, Dagoglu N, Tseng JF, Khawaja K, Evenson A.

Cureus. 2015 Aug 10;7(8):e299. doi: 10.7759/cureus.299.

7.
8.

Hepatectomy, combined with intraoperative radiofrequency ablation in patients with multiple hepatocellular carcinomas.

Lee SJ, Cho EH, Kim R, Kim YH, Lim CS, Kim SB.

Korean J Hepatobiliary Pancreat Surg. 2015 Aug;19(3):98-102. doi: 10.14701/kjhbps.2015.19.3.98. Epub 2015 Aug 28.

9.

Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization).

Hass P, Mohnike K.

Viszeralmedizin. 2014 Aug;30(4):245-52. doi: 10.1159/000366088. Review.

10.

Liver-directed therapies in metastatic colorectal cancer.

Clark ME, Smith RR.

J Gastrointest Oncol. 2014 Oct;5(5):374-87. doi: 10.3978/j.issn.2078-6891.2014.064. Review.

11.

Laparoscopic-assisted ablation of hepatic tumors: a review.

Pepple PT, Gerber DA.

Semin Intervent Radiol. 2014 Jun;31(2):125-8. doi: 10.1055/s-0034-1373787. Review.

12.

Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study.

Riou O, Serrano B, Azria D, Paulmier B, Villeneuve R, Fenoglietto P, Artenie A, Ortholan C, Faraggi M, Thariat J.

Radiat Oncol. 2014 Jun 2;9:127. doi: 10.1186/1748-717X-9-127.

13.

Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Saied A, Katz SC, Espat NJ.

Hepatobiliary Surg Nutr. 2013 Apr;2(2):97-107. doi: 10.3978/j.issn.2304-3881.2012.12.07. Review.

14.

Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases.

Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL.

J Gastrointest Oncol. 2014 Feb;5(1):46-56. doi: 10.3978/j.issn.2078-6891.2013.055.

15.

Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan-Experience of High Volume Oncologic Institute.

Granata V, Petrillo M, Fusco R, Setola SV, de Lutio di Castelguidone E, Catalano O, Piccirillo M, Albino V, Izzo F, Petrillo A.

Gastroenterol Res Pract. 2013;2013:469097. doi: 10.1155/2013/469097. Epub 2013 Nov 12.

16.

Near-infrared fluorescence-guided resection of colorectal liver metastases.

van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Cancer. 2013 Sep 15;119(18):3411-8. doi: 10.1002/cncr.28203. Epub 2013 Jun 21.

17.

Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses.

Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ.

PLoS One. 2012;7(10):e48049. doi: 10.1371/journal.pone.0048049. Epub 2012 Oct 25.

18.

Safety and efficacy of laparoscopic radiofrequency ablation for hepatic malignancies.

Lee SD, Han HS, Cho JY, Yoon YS, Hwang DW, Jung K, Yoon CJ, Kwon Y, Kim JH.

J Korean Surg Soc. 2012 Jul;83(1):36-42. doi: 10.4174/jkss.2012.83.1.36. Epub 2012 Jun 26.

19.

Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light.

Verbeek FP, van der Vorst JR, Schaafsma BE, Hutteman M, Bonsing BA, van Leeuwen FW, Frangioni JV, van de Velde CJ, Swijnenburg RJ, Vahrmeijer AL.

J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):626-37. doi: 10.1007/s00534-012-0534-6. Review.

20.

Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.

Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75. doi: 10.1007/s00270-012-0377-1. Epub 2012 Apr 26.

Supplemental Content

Support Center